About Esplanade Ventures
Esplanade Ventures is a venture capital firm founded in 2019. It is primarily based out of Montreal, Canada. As of Aug 2026, Esplanade Ventures is an active investor, having invested in 24 companies, with 3 new investments in the last 12 months. It primarily invests in Seed round in Canada based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and High Tech. Most recently it participated in the $***** Series B round of QuantHealth Overall, Esplanade Ventures portfolio has seen 2 acquisitions, namely BrainBox AI and Carebook. A lot of funds co-invest with Esplanade Ventures, with names like DigiTx Partners sharing a substantial percentage of its portfolio. Esplanade Ventures has team of 6 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio Acquisitions
Deals in last 12 months
Esplanade Ventures' List of Top Investments
Esplanade Ventures has a portfolio of 24 companies. Their most notable investments are in BrainBox AI and Tali AI.Their portfolio spans across United States, Canada and Israel. They have invested in HealthTech, Enterprise Applications, High Tech and 10 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Esplanade Ventures:
1. Neura Health
Mobile app offering remote consulting services with neurologists. The app helps users to book online appointments with neurologists for headache and migraine pain consultation. Users can seek medical guidance and order their prescribed medicines using the app.
Key facts about Neura Health
- Founded Year: 2020
- Location: New York (United States)
- Stage: Series A
- Total Funding till date: $22M
- Employee Count: 57 as on Aug 31, 2026
- Investors: Global Founders Capital, Norwest and 12 Others
- Latest Funding Round: Series A, Sep 29, 2025, $*****
- Highlight: Editors' Pick
2. BrainBox AI
Developer of an AI platform for building HVAC system optimization. The platform autonomously optimizes HVAC systems to reduce energy consumption. It offers a cloud building management system for portfolio-wide control. The company provides resources, including articles, case studies, and tools, related to AI and sustainability.
Key facts about BrainBox AI
- Founded Year: 2017
- Location: Montreal (Canada)
- Stage: Acquired
- Total Funding till date: $92.8M
- Employee Count: 200 as on Jan 02, 2026
- Investors: Export Development Canada, Quebec and 7 Others
- Latest Funding Round: Series B, Apr 28, 2023, $*****
- Highlight: Acquired
3. Cleerly
Provider of an AI-driven platform for coronary artery disease assessment. The platform quantifies atherosclerosis by measuring plaque volume, composition, length, and location. It evaluates stenosis severity and determines the likely presence or absence of ischemia. The software aims to reduce the need for additional testing and enhance diagnostic confidence.
Key facts about Cleerly
- Founded Year: 2016
- Location: Denver (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $578M
- Employee Count: 359 as on Jun 30, 2026
- Investors: T. Rowe Price, Fidelity Investments and 20 Others
- Latest Funding Round: Series C, Nov 19, 2024, $*****
- Highlight: Editors' Pick
4. EMBR labs
Provider of a wearable device for monitoring body temperature. The device offers cooling and warming sensations through a wristband. It utilizes thermal waves to stimulate temperature sensitive nerves. The device is designed to provide relief for thermal discomfort. The related mobile application allows users to personalize the experience. The device is worn on the wrist, which is an area of blood flow, and cools or warms the body at a rate of about 0.4 degrees Celsius per second. The prototype consists of a copper alloy based heat sink and a system to control thermal impulses.
Key facts about EMBR labs
- Founded Year: 2014
- Location: Boston (United States)
- Stage: Series B
- Total Funding till date: $15M
- Employee Count: 18 as on Aug 31, 2026
- Investors: Bose Ventures, Aon and 14 Others
- Latest Funding Round: Series B, Oct 16, 2024, $*****
- Highlight: Editors' Pick
5. Osteoboost
Provider of a wearable medical device that utilizes targeted mechanical stimulation to deliver patented therapy for low bone density. The device offers a non-pharmacological treatment option for postmenopausal women with osteopenia that provides precise vibrations to the lumbar spine and hips to reduce bone strength and density decline.
Key facts about Osteoboost
- Founded Year: 2018
- Location: San Francisco (United States)
- Stage: Series A
- Total Funding till date: $16M
- Employee Count: 7 as on Nov 14, 2025
- Investors: For Good Ventures, Portfolia and 14 Others
- Latest Funding Round: Series A, Apr 15, 2026, $*****
- Highlight: Editors' Pick
Esplanade Ventures' Year-on-Year Investment Trends
Esplanade Ventures has invested in 24 companies over the last 6 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 3 investments, while as of Aug 2026, it has made 2 investments in this year. Its most recent first time investment was in QuantHealth and most recent follow-on round was in Osteoboost.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 3 | 0 | 3 |
2024 | 0 | 0 | 0 |
2023 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2021 | 2 | 1 | 3 |
2020 | 2 | 0 | 2 |
Esplanade Ventures' Investments by Stage
Esplanade Ventures has made 6 investments in Seed stage with an average round size of $3.14M, 3 investments in Series A stage with an average round size of $8.31M and 2 investments in Series B stage with an average round size of $29.2M.Stage of entry | No. of Investments |
|---|---|
Seed | 6 |
Series A | 3 |
Series B | 2 |
Note: We have considered here, only first round of investments
Esplanade Ventures' Investments by Sector
Esplanade Ventures has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Artificial Intelligence - Industry Applications, Vertical SaaS and Life Sciences. Notably, it has invested in 23 Tech companies, 18 Software companies, 15 Enterprise (B2B) companies and at least 12 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 7 |
Enterprise Applications | 6 |
Artificial Intelligence - Industry Applications | 4 |
Vertical SaaS | 4 |
Life Sciences | 3 |
Others | 13 |
Note: We have considered here, only first round of investments
Esplanade Ventures' Investments by Geography
Esplanade Ventures has made most investments in Canada (5), followed by United States where it has made 3 investments.Country | No. of Investments |
|---|---|
Canada | 5 |
United States | 3 |
Israel | 2 |
Note: We have considered here, only first round of investments
Esplanade Ventures' recent investments
Esplanade Ventures has made 2 investments in 2026 so far - QuantHealth and Osteoboost.Here are the most recent investments by Esplanade Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 04, 2026 | Israel | Series B | 8712 | [+6] | |
Apr 15, 2026 | United States | Series A | 8732 | ||
Nov 17, 2025 | United States | Seed | 7927 | [+2] | |
Sep 29, 2025 | United States | Series A | 2759 | ||
Feb 11, 2025 | - | Seed | 1020 | [+4] |
Acquired companies in Esplanade Ventures' Portfolio
2 companies from Esplanade Ventures' portfolio have been acquired. The most recent acquisition was Carebook in Jan 2025 by UIL for $*****.Here are Esplanade Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 02, 2025 | - | - | 8914 | |
Dec 18, 2024 | Apr 28, 2020 | Series A | 4253 |
Team profile of Esplanade Ventures
Esplanade Ventures has a team of 6 members including 5 Partners and 1 Principal located in Canada. Esplanade Ventures' team sits on the board of 2 companies.Here is a list of all team members in Esplanade Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Montreal | |||
Partner | Canada | - | ||
Partner | Vancouver | - | ||
Partner | Toronto | |||
Partner | Montreal | - | ||
Principal | Toronto | - |
Co-investors of Esplanade Ventures
Over the past 6 years, 74 investors have co-invested in Esplanade Ventures's portfolio companies. This includes funds and angels.
- Invested before Esplanade Ventures: Pear VC, Global Founders Capital and 33 others have invested in rounds before Esplanade Ventures. There is 1 company where Pear VC has invested before Esplanade Ventures and 1 company where Global Founders Capital has invested before Esplanade Ventures.
- Top Co-investors of Esplanade Ventures: 32 investors entered a company along with Esplanade Ventures. These include investors like DigiTx Partners (2 companies).
- Invested after Esplanade Ventures: A total of 7 investors have invested in Esplanade Ventures's portfolio after their investments. Top Investors include Sustainable Development Technology Canada (1 company), Quebec (1 company) and ABB (1 company).
Recent News related to Esplanade Ventures
•
QuantHealth Secures $45 Million Series B for AI Clinical Simulation PlatformHIT Consultant•Aug 05, 2026•Qumra Capital, QuantHealth, Sanofi Ventures, Pitango and 4 others
•
Osteoboost Health Secures $8M for FDA-Cleared Bone Density DeviceHIT Consultant•Apr 15, 2026•Osteoboost, Disrupt Technology Venture, Portfolia, Ambit Health Ventures and 1 other
•
No Barrier Secures $2.7M to Enhance AI Medical Translation and AccessHIT Consultant•Nov 17, 2025•No Barrier AI, Blue Owl, Mobilization For Justice, Arkin and 4 others
•
Neura Health Secures $11.4 Million Series A for National ExpansionBenzinga•Sep 29, 2025•Neura Health, American Heart Association, E12 Ventures, Koch Disruptive Technologies and 3 others
•
Latham & Watkins Advises Cerula Care in US$3.7 Million Seed FinancingLegal Desire•Feb 15, 2025•Latham & Watkins, Cerula Care, Esplanade Ventures, Amplify Capital and 3 others
•
Cerula Care raises $3.7M seed round to support cancer patients’ mental healthEndPoints News•Feb 12, 2025•Cerula Care, Esplanade Ventures, Amplify Capital, BrightEdge and 5 others
•
Bone Health Technologies Raises $5M to Launch Bone Density WearableMedical Device News•Mar 04, 2024•Esplanade Ventures, Osteoboost, Berkeley Catalyst Fund, Bone Health Technologies and 2 others
•
•
BrainBox AI announces $24 million to fuel energy-saving tech for Commercial BuildingsBetaKit•Oct 30, 2021•BrainBox AI, Esplanade Ventures, Desjardins, ABB and 2 others
•
